Wael El-Rifai

Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers. Read More

New findings that reveal complex interactions in esophageal adenocarcinoma could lead to diagnostic, prognostic or therapeutic biomarkers. Read More

A signaling protein overexpressed in upper gastrointestinal cancers is an attractive therapeutic target. Read More

Nine Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year. Read More

Vanderbilt researchers have discovered a link between Helicobacter pylori infection, inflammation and gastric cancer that could suggest new anti-cancer therapies. Read More

Vanderbilt scientists have discovered a new molecular mechanism that promotes stomach cancer development, findings that could provide new opportunities for treatment. Read More

A protein kinase linked to inflammation and tumor development may be a good target for gastric cancer therapies. Read More

An antioxidant enzyme also functions as a tumor suppressor to limit cancer development in the esophagus. Read More

Dysfunction or loss of an “antioxidant” enzyme may lead to higher risk for esophageal cancer in patients with gastric reflux disease. Read More

The outstanding academic achievements of 11 faculty members who have been named to endowed chairs were praised during a celebration at the Student Life Center. Read More

A protein critical in heart development may also play a part in colon cancer progression. Read More